Ocugen (OCGN) Operating Leases (2019 - 2026)
Ocugen (OCGN) posted Operating Leases of $4.1 million for Q1 2026, up 17.4% on a QoQ basis from $3.5 million in Q4 2025, and up 20.01% year-over-year from $3.4 million in Q1 2025.
Ocugen (OCGN) Operating Leases (2019 - 2026) Analysis & Trends
Ocugen's Operating Leases history runs 8 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- Quarterly Operating Leases rose 20.01% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 20.01% YoY) and the FY2025 annual result came in at $3.5 million, down 8.82% from the prior year.
- Operating Leases was $4.1 million for Q1 2026 at Ocugen, up from $3.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $4.8 million in Q2 2025 and bottomed at $1.2 million in Q1 2022.
- A 5-year average of $3.6 million and a median of $3.8 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases surged 231.84% — and 2023, when it decreased 15.94%.
- Ocugen's Operating Leases stood at $4.1 million in 2022, then dropped by 12.68% to $3.6 million in 2023, then advanced by 7.43% to $3.8 million in 2024, then declined by 8.82% to $3.5 million in 2025, then gained by 17.4% to $4.1 million in 2026.
- Business Quant data shows OCGN's Operating Leases at $4.1 million in Q1 2026, $3.5 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Sep 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 3.31 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 3.76 Mn |
| Jun 30, 2022 | 3.89 Mn |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.33 Mn |